Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy

Clinical trial NCT00216567 · COMPLETED

Trial details

NCT number: NCT00216567
Sponsor: Janssen Korea, Ltd., Korea
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Epilepsy, Rolandic

Start date: 2002-12-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.